0

Novo Nordisk CEO’s testimony before US Senate panel set for Sept. 24 – ET HealthWorld | Pharma

Washington: Novo Nordisk chief executive Lars Jorgensen’S testimony before the US Senate Health Committee US prices For weight loss medications Ozempic and Wegovy will be held gharanaSenator Bernie Sanders, the committee chairman, said on Monday that 24.

The Senate Committee on Health, Education, Labor and Pensions said earlier this month that Jorgensen had agreed to voluntarily testify at a hearing but did not specify a date.

“The committee hopes to hear from Mr. Jorgensen an answer to a very simple question: Why does he think it is acceptable to charge Americans 10 or 15 times more for Ozempic and Wegovy than people in Europe and other leading countries,” Sanders said in a statement.

(Report by Ahmed Aboulenein)

  • Published on June 25, 2024, 10:27 AM IST

Join a community of 2M+ industry professionals

Subscribe to our newsletter to get the latest information and analysis.

Download ETHealthworld App

  • Get realtime updates
  • Save your favourite articles

icon g play - 2

icon app store - 4


Scan to download the app
health barcode - 6

novo-nordisk-ceos-testimony-before-us-senate-panel-set-for-sept-24-et-healthworld-pharma